Caplin Point Laboratories Limited (CAPLIPOINT:NSE) Annual Income Statement ()
CAPLIPOINT:NSE Quarterly Financials ()
Frequently Asked Questions About Caplin Point Laboratories Limited (CAPLIPOINT:NSE) Stock
Caplin Point Laboratories Limited's (CAPLIPOINT:NSE) last reported annual revenue was INR 14.67 Billion.
Caplin Point Laboratories Limited's (CAPLIPOINT:NSE) annual revenue growth rate based on the revenue reported in the past 5 years is : 17.72%
Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) is profitable as of its last reported annual financials.
The net profit margin for Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) from its laster reported year is 31.16%
The return on equity (ROE) for Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) from its last reported annual financials is : 21.69%
The return on assets (ROA) for Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) from its last reported annual financials is : 12.73%
The return on invested capital (ROIC) for Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) from its last reported annual financials is : 15.32%
The Debt to Equity ratio for Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) from its last reported annual financials is : 0.00%
The dividend yield for Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) from its laster reported year is 0.26%
Caplin Point Laboratories Limited's(CAPLIPOINT:NSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CAPLIPOINT:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
